RANDAL J KIRK Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).

Latest Insider Trading Transactions of RANDAL J KIRK

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP

Page:   < prev 1 ... 2 3 4 5 6

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0024,5830843,044818.5 K to 843 K (+3.00 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.002,016075,68473.7 K to 75.7 K (+2.74 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0020,9760850,355829.4 K to 850.4 K (+2.53 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0020,9760720,562699.6 K to 720.6 K (+3.00 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.008,9770114,181105.2 K to 114.2 K (+8.53 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.008,9770140,007131 K to 140 K (+6.85 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.008,9770139,052130.1 K to 139.1 K (+6.90 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0033501,4031.1 K to 1.4 K (+31.37 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0073,7630311,287237.5 K to 311.3 K (+31.05 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.00334,73705,231,5554.9 M to 5.2 M (+6.84 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...SellJ0.001,196,077001.2 M to 0 (-100.00 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA30.746,506199,9944,896,8184.9 M to 4.9 M (+0.13 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA24.3532,854799,995182,476149.6 K to 182.5 K (+21.96 %)
May 16 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP23.9241,8301,000,5746,649,9976.6 M to 6.6 M (+0.63 %)
May 05 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorGrantA0.0020,20203,538,2533.5 M to 3.5 M (+0.57 %)
May 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA37.9621,074799,969149,622128.5 K to 149.6 K (+16.39 %)
May 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA26.737,482199,9944,890,3124.9 M to 4.9 M (+0.15 %)
Apr 04 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA34.1923,398799,978128,548105.2 K to 128.5 K (+22.25 %)
Apr 04 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA33.895,901199,9854,882,8304.9 M to 4.9 M (+0.12 %)
Mar 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA29.6726,963799,992105,15078.2 K to 105.2 K (+34.49 %)
Mar 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA30.956,462199,9994,876,9294.9 M to 4.9 M (+0.13 %)
Feb 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA27.1129,509799,98978,18748.7 K to 78.2 K (+60.62 %)
Feb 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA29.146,863199,9884,870,4674.9 M to 4.9 M (+0.14 %)
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseP1.2132,20538,96832,205
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseP0.0042,941042,941
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseP1.2132,20538,96832,205
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseP0.0042,941042,941
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseP1.2132,20538,96832,205
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseP0.0042,941042,941
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseP1.2164,41177,93764,411
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseP0.0085,882085,882
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseC0.00577,31900
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseC0.00288,65900
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseC0.00517,24100
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseC0.001,034,48200
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseC0.00577,31900
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerOption ExerciseC0.001,034,48200
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerBuyP1.00317,294317,294894,613577.3 K to 894.6 K (+54.96 %)
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerBuyC0.00577,3190577,3190 to 577.3 K
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerBuyP1.00894,965894,9651,510,135615.2 K to 1.5 M (+145.48 %)
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerBuyC0.00461,0720615,170154.1 K to 615.2 K (+299.21 %)
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerBuyP1.001,472,6361,472,6362,125,654653 K to 2.1 M (+225.51 %)
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerBuyC0.00344,8220653,018308.2 K to 653 K (+111.88 %)
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerBuyP1.001,789,9301,789,9303,020,2671.2 M to 3 M (+145.48 %)
Jan 11 2016TBIOTRANSGENOMIC INCKIRK RANDAL J10% OwnerBuyC0.00922,14101,230,337308.2 K to 1.2 M (+299.21 %)
Jan 05 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA30.7226,041799,98048,67822.6 K to 48.7 K (+115.04 %)
Jan 05 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA30.156,633199,9854,863,6044.9 M to 4.9 M (+0.14 %)
Jan 04 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorGrantA0.0026,6610122,30995.6 K to 122.3 K (+27.87 %)
Dec 14 2015XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP29.8334,1001,017,2036,608,1676.6 M to 6.6 M (+0.52 %)
Dec 14 2015XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP29.8690,3752,698,5986,574,0676.5 M to 6.6 M (+1.39 %)
Dec 07 2015XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP30.69237,5257,289,6426,483,6926.2 M to 6.5 M (+3.80 %)
Dec 03 2015XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA35.3422,637799,99222,6370 to 22.6 K
Dec 03 2015XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GiftG0.0020004,856,9714.9 M to 4.9 M (0.00 %)
Dec 03 2015XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA36.315,508199,9954,857,1714.9 M to 4.9 M (+0.11 %)
Dec 03 2015XONINTREXON CORPKIRK RANDAL J10% OwnerBuyC1.503,381,0045,071,50612,219,6708.8 M to 12.2 M (+38.25 %)
Dec 03 2015OGENORAGENICS INCKIRK RANDAL J10% OwnerBuyC1.503,381,0045,071,50612,219,6708.8 M to 12.2 M (+38.25 %)
Sep 04 2015XONINTREXON CORPKIRK RANDAL J10% OwnerBuyP3.20937,5003,000,0009,613,2688.7 M to 9.6 M (+10.81 %)
Sep 04 2015SYNSynthetic Biologic ...KIRK RANDAL J10% OwnerBuyP3.20937,5003,000,0009,613,2688.7 M to 9.6 M (+10.81 %)
Jul 27 2015XONINTREXON CORPKIRK RANDAL J10% OwnerBuyP5.80375,8682,180,0346,400,7836 M to 6.4 M (+6.24 %)
Jul 27 2015XONINTREXON CORPKIRK RANDAL J10% OwnerBuyP5.8018,003104,41718,0030 to 18 K
Jul 27 2015XONINTREXON CORPKIRK RANDAL J10% OwnerBuyP5.80582,1163,376,273582,1160 to 582.1 K
Jul 27 2015FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerBuyP5.80375,8682,180,0346,400,7836 M to 6.4 M (+6.24 %)
Jul 27 2015FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerBuyP5.8018,003104,41718,0030 to 18 K
Jul 27 2015FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerBuyP5.80582,1163,376,273582,1160 to 582.1 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0086,556086,5560 to 86.6 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00173,1110173,1110 to 173.1 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0058,746058,7460 to 58.7 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00176,2380176,2380 to 176.2 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00352,4770352,4770 to 352.5 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00111,3390111,3390 to 111.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00222,6800222,6800 to 222.7 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00395,7910395,7910 to 395.8 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00889,5130889,5130 to 889.5 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.001,013,14602,359,6081.3 M to 2.4 M (+75.25 %)
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0061,262061,2620 to 61.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00138,9750138,9750 to 139 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00154,1810154,1810 to 154.2 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0029,066029,0660 to 29.1 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0034,318034,3180 to 34.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00358,3860358,3860 to 358.4 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00337,3330337,3330 to 337.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.009,53709,5370 to 9.5 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0053,245053,2450 to 53.2 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0024002400 to 240
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0040,954040,9540 to 41 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0023,504023,5040 to 23.5 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0023,349023,3490 to 23.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.003,479,00603,479,0060 to 3.5 M
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorSellJ0.0017,830,3050017.8 M to 0 (-100.00 %)
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0086,556086,5560 to 86.6 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00173,1110173,1110 to 173.1 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0058,746058,7460 to 58.7 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00176,2380176,2380 to 176.2 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00352,4770352,4770 to 352.5 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00111,3390111,3390 to 111.3 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00222,6800222,6800 to 222.7 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00395,7910395,7910 to 395.8 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00889,5130889,5130 to 889.5 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.001,013,14602,359,6081.3 M to 2.4 M (+75.25 %)
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0061,262061,2620 to 61.3 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00138,9750138,9750 to 139 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00154,1810154,1810 to 154.2 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0029,066029,0660 to 29.1 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0034,318034,3180 to 34.3 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00358,3860358,3860 to 358.4 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.00337,3330337,3330 to 337.3 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.009,53709,5370 to 9.5 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0053,245053,2450 to 53.2 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0024002400 to 240
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0040,954040,9540 to 41 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0023,504023,5040 to 23.5 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.0023,349023,3490 to 23.3 K
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorBuyJ0.003,479,00603,479,0060 to 3.5 M
Jun 08 2015XONINTREXON CORPKIRK RANDAL JDirectorSellJ0.0017,830,3050017.8 M to 0 (-100.00 %)
May 08 2015GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorGrantA0.0013,17503,518,0513.5 M to 3.5 M (+0.38 %)
Mar 18 2015XONINTREXON CORPKIRK RANDAL J10% OwnerOption ExerciseP0.223,484,848749,2423,484,848
Mar 18 2015XONINTREXON CORPKIRK RANDAL J10% OwnerBuyP0.1713,939,3922,300,00037,939,39224 M to 37.9 M (+58.08 %)
Mar 18 2015APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerOption ExerciseP0.223,484,848749,2423,484,848
Mar 18 2015APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerBuyP0.1713,939,3922,300,00037,939,39224 M to 37.9 M (+58.08 %)
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorOption ExerciseC0.0011,28900
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorOption ExerciseC0.0041,68200
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorOption ExerciseC0.002,38800
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorOption ExerciseC0.0048,08500
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorOption ExerciseC0.0037,71600
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorOption ExerciseC0.0061,50500
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorBuyC0.00112,8900112,8900 to 112.9 K
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorBuyC0.00416,8200555,162138.3 K to 555.2 K (+301.30 %)
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorBuyC0.0023,880033,0919.2 K to 33.1 K (+259.26 %)
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorBuyC0.00480,8500579,88399 K to 579.9 K (+485.55 %)
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorBuyC0.00377,1600433,41056.3 K to 433.4 K (+670.51 %)
Nov 13 2003NOVICLINICAL DATA INCKIRK RANDAL JDirectorBuyC0.00615,05001,048,191433.1 K to 1 M (+142.00 %)

Page:   < prev 1 ... 2 3 4 5 6